{"entity":{"type":"insider","cik":"0001465144","url":"/insider/0001465144","json_url":"/insider/0001465144.json","name":"Domain Partners VIII, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2012-07-24","last":"2018-08-27","span_basis":"filed_date"},"name_variants":[{"name":"Domain Partners VIII, L.P.","source":"filing","n_filings":3,"first_seen":"2012-07-24","last_seen":"2018-08-27"}],"transactions":[{"id":6254408,"accession":"0000904454-18-000522","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-18-000522","line_url":"/filing/0000904454-18-000522#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"BioNano Genomics, Inc","issuer_ticker":"BNGO","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; VITULLO NICOLE; Halak Brian K; BLAIR JAMES C; Domain Partners VIII, L.P.; DOVEY BRIAN H","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":6.125,"price_display":"6.12","price_state":"stated","total_value":91875.0,"total_display":"91,875.00","total_whole":"91,875","shares_owned_after":943878.0,"shares_owned_after_display":"943,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-27","scope":"insider"},{"id":6330122,"accession":"0000904454-14-000719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-14-000719","line_url":"/filing/0000904454-14-000719#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; Halak Brian K; DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; Domain Partners VIII, L.P.; TREU JESSE I","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":248159.0,"shares_display":"248,159","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":2729749.0,"total_display":"2,729,749.00","total_whole":"2,729,749","shares_owned_after":2141542.0,"shares_owned_after_display":"2,141,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-21","filed_date":"2014-10-21","scope":"insider"},{"id":2280835,"accession":"0000904454-12-000372","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-12-000372","line_url":"/filing/0000904454-12-000372#line-2","is_derivative":false,"issuer_cik":"0001465144","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001465144","owner_cik":"0001465144","owner_name":"Domain Partners VIII, L.P.","owner_display_name":"Domain Partners VIII, L.P.","owner_url":"/insider/0001465144","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":778536.0,"shares_display":"778,536","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":7006824.0,"total_display":"7,006,824.00","total_whole":"7,006,824","shares_owned_after":3006132.0,"shares_owned_after_display":"3,006,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-24","filed_date":"2012-07-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001411690","name":"BioNano Genomics, Inc","url":"/issuer/0001411690","role":"Ten percent owner","n_filings":1,"first_seen":"2018-08-27","last_seen":"2018-08-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Ten percent owner","n_filings":1,"first_seen":"2014-10-21","last_seen":"2014-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001544116","name":"Durata Therapeutics, Inc.","url":"/issuer/0001544116","role":"Ten percent owner","n_filings":1,"first_seen":"2012-07-24","last_seen":"2012-07-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001465144","retrieved_at":"2026-08-25T05:09:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}